NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Wiki Markup
{scrollbar:icons=false}

Page info
title
title

 

{multi-excerpt:name=}
Wiki Markup
Multiexcerpt
MultiExcerptNameUserProfiles-GovernmentandStandardsOrganizations

 

NCI

EVS

has

extensive

partnerships

with

government

and

standards

organizations

beyond

NIH

to

develop

terminology

standards,

content,

technology,

and

operational

support.

 

  Such

partnerships

are

designed

to

directly

support

NCI's

cancer

research

mission,

improving

regulatory,

federal

and

community

practices

in

ways

that

contribute

to

the

conduct

and

sharing

of

cancer

research

while

also

having

a

positive

impact

on

the

wider

biomedical

community.

The

following

collaborations

are

included

in

this

section:

{

Table of Contents

:

minLevel

=2} h2.

2

U.S.

Food

and

Drug

Administration

(FDA)

FDA

has

worked

with

EVS

since

2001,

with

formal

Memoranda

of

Understanding

starting

in

2004,

to

develop

and

harmonize

terminology

content,

standards

and

systems

in

areas

of

mutual

interest

such

as

drugs,

devices,

patient

safety,

and

clinical

trials.

FDA

has

chosen

EVS

and

NCI

Thesaurus

(NCIt)

for

developing

and

publishing

many

important

terminology

sets;

some

15,000

FDA

terms

in

over

20

defined

subsets

are

now

maintained

in

NCIt

and

required

for

regulatory

reporting

and

other

purposes.

These

include:

* *

  • Structured
  • Product
  • Labeling
  • (SPL):
*
  • Standard
  • terminology
  • for
  • Drug
  • Establishment
  • Registration
  • (Regulated
  • Product
  • Submission),
  • Drug
  • Listing
  • and
  • the
  • Content
  • of
  • Labels.
  • 16
  • NCIt
  • subsets
  • used
  • for
  • submission
  • of
  • proposed
  • labeling
  • by
  • all
  • manufacturers
  • using
  • electronic
  • formats.
  • There
  • are
  • 9,466
  • establishments
  • from
  • over
  • 100
  • countries
  • that
  • use
  • the
  • SPL
  • terminology
  • in
  • order
  • to
  • comply
  • with
  • federal
  • regulations
  • to
  • list
  • their
  • products.
  • There
  • are
  • approximately
  • 40,000
  • subscribers
  • to
  • the
  • FDA's
  • SPL
  • LISTSERV,
  • and
  • this
  • is
  • one
  • of
  • the
  • primary
  • mechanisms
  • to
  • inform
  • users
  • of
  • changes
  • to
  • the
  • SPL
  • terminology
  • that
  • is
  • maintained
  • by
  • NCI.
  • FDA
  • does
  • not
  • track
  • the
  • number
  • of
  • hits
against [http://www.fda.gov/ForIndustry/DataStandards/default.htm|http://www.fda.gov/ForIndustry/DataStandards/default.htm] and its sub pages, but they suspect that the number of hits is very high; when firms do not select the correct NCIt code, their submitted SPL file will not pass validation. * *Unique Ingredient Identifier (UNII)* codes are being developed by FDA to uniquely identify all ingredients used in marketed medications in the United States, as well as substances in biologics, foods and devices. Each UNII is assigned based on molecular structure or other immutable characteristics. FDA provides a [full set of published UNII codes|http://fdasis.nlm.nih.gov/srs/jsp/srs/uniiListDownload.jsp] and a [search page|http://fdasis.nlm.nih.gov/srs/srs.jsp] on a Web site now hosted by the National Library of Medicine (NLM) and updated approximately monthly. * * EVS collaborated with FDA on the launch and early publication of UNII codes. More than 12,000 UNII codes have been included in corresponding NCIt concepts, and more continue to be added each month, although NCIt no longer provides comprehensive representation of all UNII concepts. Most of these 12,000 concepts were included in NCIt because of their therapeutic and other interest for cancer and related research, and they are extensively annotated with definitions, chemical formulae, CAS registry numbers, synonyms, and other information to help support such research. Files providing UNIIs that have matching NCIt concept codes are available for download in [Excel|http://evs.nci.nih.gov/ftp1/FDA/UNII/FDA-UNII_NCIt_Subsets.xls] and [text|http://evs.nci.nih.gov/ftp1/FDA/UNII/FDA-UNII_NCIt_Subsets.txt] formats. * *CDRH Device Event Problem Codes:* NCIt subsets used for the reporting of medical device problems to FDA. CDRH is responsible for ensuring the safety and effectiveness of medical devices and eliminating unnecessary human exposure to man-made radiation from medical, occupational and consumer products. Approximately 200 organizations from some 3,000 different reporting locations report to the CDRH using NCIt terminology. CDRH receives approximately 35,000 submissions per month that are based on NCIt terminology. * *Individual Case Safety Report (ICSR):* NCIt subsets used for adverse event reporting. Proposed regulations for electronic submissions will create similar levels of use for these subsets. * *eCTD (electronic Common Technical Documents):* Standard terminology for regulatory forms required by the Center for Drug Evaluation and Research (CDER). * *Drug Submissions*: Beginning June 1, 2009, FDA no longer accepts paper submissions for drug establishment registration and listing unless a waiver is granted. Moving from a paper-based format to an electronic system will improve the timeliness and accuracy of the submissions. This is not possible without the terminology provided by NCIt. Of 22,246 New Drug related Submissions from October 2009 - September 2010, (63%) were in electronic format submissions that required terminology from NCIt. * *Stability*: NCIt provides terminology for FDA and HL7 Stability Data Standards, including human pharmaceuticals, animal drugs and medical devices that are in regulatory submissions, amendments, supplements and annual reports. EVS resources and systems are also used in FDA efforts such as the [*Janus Clinical Trials Repository (CTR) Project*|http://www.fda.gov/ForIndustry/DataStandards/StudyDataStandards/ucm155327.htm], a standards-based repository of subject level clinical trial data to support regulatory review and patient centered outcomes research (PCOR). For more information, visit the NCI website [http://www.cancer.gov/cancertopics/cancerlibrary/terminologyresources/FDA|http://www.cancer.gov/cancertopics/cancerlibrary/terminologyresources/FDA|http://www.cancer.gov/cancertopics/cancerlibrary/terminologyresources/FDA]. +EVS Related References+ # McCullough CE, Reed TL, Kaufman-Rivi D. *A Tool to Analyze Medical Device Problems: The Food and Drug Administration Device Problem Codes.* ??J Clinical Engineering??. 2012
  • against the FDA Resources for Data Standards page and its sub pages, but they suspect that the number of hits is very high; when firms do not select the correct NCIt code, their submitted SPL file will not pass validation.
  • Unique Ingredient Identifier (UNII) codes are being developed by FDA to uniquely identify all ingredients used in marketed medications in the United States, as well as substances in biologics, foods and devices. Each UNII is assigned based on molecular structure or other immutable characteristics. FDA provides a full set of published UNII codes and a search page on a Web site now hosted by the National Library of Medicine (NLM) and updated approximately monthly.
     
    EVS collaborated with FDA on the launch and early publication of UNII codes. More than 12,000 UNII codes have been included in corresponding NCIt concepts, and more continue to be added each month, although NCIt no longer provides comprehensive representation of all UNII concepts. Most of these 12,000 concepts were included in NCIt because of their therapeutic and other interest for cancer and related research, and they are extensively annotated with definitions, chemical formulae, CAS registry numbers, synonyms, and other information to help support such research. Files providing UNIIs that have matching NCIt concept codes are available for download in Excel and text formats.
  • CDRH Device Event Problem Codes: NCIt subsets used for the reporting of medical device problems to FDA. CDRH is responsible for ensuring the safety and effectiveness of medical devices and eliminating unnecessary human exposure to man-made radiation from medical, occupational and consumer products. Approximately 200 organizations from some 3,000 different reporting locations report to the CDRH using NCIt terminology. CDRH receives approximately 35,000 submissions per month that are based on NCIt terminology.
  • Individual Case Safety Report (ICSR): NCIt subsets used for adverse event reporting. Proposed regulations for electronic submissions will create similar levels of use for these subsets.
  • eCTD (electronic Common Technical Documents): Standard terminology for regulatory forms required by the Center for Drug Evaluation and Research (CDER).
  • Drug Submissions: Beginning June 1, 2009, FDA no longer accepts paper submissions for drug establishment registration and listing unless a waiver is granted. Moving from a paper-based format to an electronic system will improve the timeliness and accuracy of the submissions. This is not possible without the terminology provided by NCIt. Of 22,246 New Drug related Submissions from October 2009 - September 2010, (63%) were in electronic format submissions that required terminology from NCIt.
  • Stability: NCIt provides terminology for FDA and HL7 Stability Data Standards, including human pharmaceuticals, animal drugs and medical devices that are in regulatory submissions, amendments, supplements and annual reports.

EVS resources and systems are also used in FDA efforts such as the Janus Clinical Trials Repository (CTR) Project, a standards-based repository of subject level clinical trial data to support regulatory review and patient centered outcomes research (PCOR).

For more information, visit the NCI website FDA terminology resources.

EVS Related References

  1. McCullough CE, Reed TL, Kaufman-Rivi D.
    A Tool to Analyze Medical Device Problems: The Food and Drug Administration Device Problem Codes.
    J Clinical Engineering. 2012 Apr/Jun;37(2):56–62.
  1. doi:
  1. 10.1097/JCE.0b013e31824c99f1
\[
  1. [Online
|http://journals.lww.com/jcejournal/Abstract/2012/04000/A_Tool_to_Analyze_Medical_Device_Problems__The.17.aspx]\] # Reed TL,
  1. ]
  2. Reed TL, Kaufman-Rivi
  1. D.
*

  1. FDA
  1. adverse
  1. Event
  1. Problem
  1. Codes:
  1. standardizing
  1. the
  1. classification
  1. of
  1. device
  1. and
  1. patient
  1. problems
  1. associated
  1. with
  1. medical
  1. device
  1. use.
* ??

  1. Biomed
  1. Instrum
  1. Technol.
??
  1. 2010
  1. May-Jun;44(3):248-56.
  1. PubMed
  1. PMID:
  1. 20715359.
\
  1. [
[
  1. PubMed
|http://www.ncbi.nlm.nih.gov/pubmed/20715359]\] h2. Clinical Data Interchange Standards Consortium (CDISC) CDISC is an international, non-profit organization that develops and supports global data standards for medical research. CDISC is working actively with EVS to develop and support controlled terminology for a wide spectrum of clinical and nonclinical studies. CDISC terminology is being widely adopted as a standard for study coding and data submissions. In the United States, draft FDA guidance on regulatory submissions (see [Study Data Technical Conformance Guide|http://www.fda.gov/downloads/ForIndustry/DataStandards/StudyDataStandards/UCM384744.pdf]) recommends CDISC terminology as a set of controlled terms that meet the FDA requirements for the implementation of the CDISC standards. As part of the General Considerations of Controlled Terminology regarding CDISC, the Guide states: "Sponsors should use the terminologies and code lists in the CDISC Controlled Terminology, which can be found at the NCI (National Cancer Institute) Enterprise Vocabulary Services." CDISC terminology goes through an extensive process of content development and public review before it is declared ready for release. All CDISC controlled terminology -- more than 10,000 terms -- is maintained and published as NCI Thesaurus (NCIt) subsets, as part of a partnership started in 2002. The main terminology efforts encompassed by the CDISC-EVS partnership are shown below: * *Study Data Tabulation Model (SDTM)* is an international standard for clinical research data, and is approved by the FDA and [Japan’s Pharmaceuticals and Medical Devices Agency (PMDA)|http://www.pmda.go.jp/english/] as a standard electronic submission format. EVS maintains and distributes SDTM controlled terminology as part of NCIt. More information is available at [CDISC's SDTM Web page|http://www.cdisc.org/sdtm]. SDTM has been downloaded more than 14,000 times in over 60 countries, primarily for institutional use. More than 270 commercial organizations use SDTM, as do numerous academic, non-profit and research organizations. * *Questionnaire (QS) and Functional Test (FT) Terminology* contains standardized, controlled terminology for commonly used questionnaires and functional tests in biomedical and therapeutic area research. EVS maintains and distributes Questionnaire controlled terminology as part of NCIt. More information is available at [CDISC's Questionnaire Web page|http://www.cdisc.org/content2909]. Questionnaire terminology can be used for both collection (CDASH) and submission (SDTM) data sets. * *Clinical Data Acquisition Standards Harmonization (CDASH)* develops clinical research study content standards in collaboration with sixteen partner organizations including NCI. EVS maintains and distributes CDASH controlled terminology, a subset of SDTM, as part of NCIt. More information is available at [CDISC's CDASH Web page|http://www.cdisc.org/cdash]. * *Analysis Data Model (ADaM)* supports efficient generation, replication, review and submission of analysis results from clinical trial data. EVS maintains and distributes ADaM controlled terminology as part of NCIt. More information is available at [CDISC's ADaM Web page|http://www.cdisc.org/adam]. * *Standard for Exchange of Non-Clinical Data (SEND)* extends Study Data Tabulation Model (SDTM) for non-clinical studies. SEND guides the organization, structure and format of standard nonclinical tabulation data sets for interchange between organizations such as sponsors and CROs and for submission to a regulatory authority such as the FDA. NCI EVS maintains and distributes SEND controlled terminology as part of NCIt. It now includes some 1,000 additional terms beyond the SDTM terminology that is also part of the SEND standard. More information is available at [CDISC's SEND Web page|http://www.cdisc.org/send]. *The CDISC Shared Health and Research Electronic Library (SHARE)* project aims to create a global, electronically accessible library of CDISC standard metadata that can be used to improve biomedical research and its link with healthcare. The SHARE metadata repository (MDR) provides a dynamic environment where the relationships between and among CDISC metadata and controlled terminologies are published at a level of granularity that is user-defined and in forms that are both human and machine readable. The SHARE MDR is built using CDISC and BRIDG metadata and terminology that is coded and maintained in the EVS NCIt environment. More information is available at [CDISC’s SHARE Web page|http://www.cdisc.org/cdisc-share]. For more information, visit the NCI website [http://www.cancer.gov/cancertopics/cancerlibrary/terminologyresources/CDISC|http://www.cancer.gov/cancertopics/cancerlibrary/terminologyresources/CDISC]. +EVS Related References+ # Elkin PL. *Springer Terminology Related Standards Development.* In Elkin PL, ed. ??Terminology and Terminological Systems??, Ch.7 pp.107-123, Springer London, 2012. \[[Springer|http://dx.doi.org/10.1007/978-1-4471-2816-8_7]\] # Haber MW, Kisler BW, Lenzen M, Wright LW. *Controlled Terminology for Clinical Research: A Collaboration between CDISC and NCI Enterprise Vocabulary Services.* ??Drug Information Journal??
  1. ]

Clinical Data Interchange Standards Consortium (CDISC)

CDISC is an international, non-profit organization that develops and supports global data standards for medical research. CDISC is working actively with EVS to develop and support controlled terminology for a wide spectrum of clinical and nonclinical studies.

CDISC terminology is being widely adopted as a standard for study coding and data submissions. In the United States, draft FDA guidance on regulatory submissions (see Study Data Technical Conformance Guide) recommends CDISC terminology as a set of controlled terms that meet the FDA requirements for the implementation of the CDISC standards. As part of the General Considerations of Controlled Terminology regarding CDISC, the Guide states: "Sponsors should use the terminologies and code lists in the CDISC Controlled Terminology, which can be found at the NCI (National Cancer Institute) Enterprise Vocabulary Services."

CDISC terminology goes through an extensive process of content development and public review before it is declared ready for release. All CDISC controlled terminology – more than 10,000 terms – is maintained and published as NCI Thesaurus (NCIt) subsets, as part of a partnership started in 2002. The main terminology efforts encompassed by the CDISC-EVS partnership are shown below:

  • Study Data Tabulation Model (SDTM) is an international standard for clinical research data, and is approved by the FDA and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) as a standard electronic submission format. EVS maintains and distributes SDTM controlled terminology as part of NCIt. More information is available at CDISC's SDTM Web page. SDTM has been downloaded more than 14,000 times in over 60 countries, primarily for institutional use. More than 270 commercial organizations use SDTM, as do numerous academic, non-profit and research organizations.
  • Questionnaire (QS) and Functional Test (FT) Terminology contains standardized, controlled terminology for commonly used questionnaires and functional tests in biomedical and therapeutic area research. EVS maintains and distributes Questionnaire controlled terminology as part of NCIt. More information is available at CDISC's Questionnaire Web page. Questionnaire terminology can be used for both collection (CDASH) and submission (SDTM) data sets.
  • Clinical Data Acquisition Standards Harmonization (CDASH) develops clinical research study content standards in collaboration with sixteen partner organizations including NCI. EVS maintains and distributes CDASH controlled terminology, a subset of SDTM, as part of NCIt. More information is available at CDISC's CDASH Web page.
  • Analysis Data Model (ADaM) supports efficient generation, replication, review and submission of analysis results from clinical trial data. EVS maintains and distributes ADaM controlled terminology as part of NCIt. More information is available at CDISC's ADaM Web page.
  • Standard for Exchange of Non-Clinical Data (SEND) extends Study Data Tabulation Model (SDTM) for non-clinical studies. SEND guides the organization, structure and format of standard nonclinical tabulation data sets for interchange between organizations such as sponsors and CROs and for submission to a regulatory authority such as the FDA. NCI EVS maintains and distributes SEND controlled terminology as part of NCIt. It now includes some 1,000 additional terms beyond the SDTM terminology that is also part of the SEND standard. More information is available at CDISC's SEND Web page.

The CDISC Shared Health and Research Electronic Library (SHARE) project aims to create a global, electronically accessible library of CDISC standard metadata that can be used to improve biomedical research and its link with healthcare. The SHARE metadata repository (MDR) provides a dynamic environment where the relationships between and among CDISC metadata and controlled terminologies are published at a level of granularity that is user-defined and in forms that are both human and machine readable. The SHARE MDR is built using CDISC and BRIDG metadata and terminology that is coded and maintained in the EVS NCIt environment. More information is available at CDISC’s SHARE Web page.

EVS Related References

  1. Elkin PL.
    Springer Terminology Related Standards Development.
    In Elkin PL, ed. Terminology and Terminological Systems, Ch.7 pp.107-123, Springer London, 2012. [Springer]
  2. Haber MW, Kisler BW, Lenzen M, Wright LW.
    Controlled Terminology for Clinical Research: A Collaboration between CDISC and NCI Enterprise Vocabulary Services.
    Drug Information Journal 2007;41(3):405-412.
\
  1. [
[PDF|http://www.cdisc.org/system/files/all/reference_material/application/pdf/diaj_terminology.pdf]\] # Jiang G, Solbrig HR, Iberson-Hurst D, Kush RD, Chute CG. *A Collaborative Framework for Representation and Harmonization of Clinical Study Data Elements Using Semantic MediaWiki.* ??AMIA Summits Transl Sci Proc. 2010?? Mar
  1. PDF]
  2. Jiang G, Solbrig HR, Iberson-Hurst D, Kush RD, Chute CG.
    A Collaborative Framework for Representation and Harmonization of Clinical Study Data Elements Using Semantic MediaWiki.
    AMIA Summits Transl Sci Proc. 2010 Mar 1;2010:11-5.
  1. PubMed
  1. PMID:
  1. 21347136;
  1. PubMed
  1. Central
  1. PMCID:
  1. PMC3041544.
\
  1. [
[
  1. PubMed
|http://www.ncbi.nlm.nih.gov/pubmed/21347136]\] # Keenan CM, Goodman DG. *Regulatory Forum Commentary: Through the Looking
  1. ]
  2. Keenan CM, Goodman DG.
    Regulatory Forum Commentary: Through the Looking Glass--SENDing
  1. the
  1. Pathology
  1. Data
  1. We
  1. Have
  1. INHAND.
* ??

  1. Toxicol
  1. Pathol
??
  1. .
  1. 2013
  1. Apr
  1. 18.
\
  1. [Epub
  1. ahead
  1. of
  1. print
\
  1. ]
  1. PubMed
  1. PMID:
  1. 23599411.
\
  1. [
[
  1. PubMed
|http://www.ncbi.nlm.nih.gov/pubmed/23599411]\] # Kush RD. *Interoperability for the Learning Health System.* ??Digital Infrastructure for the Learning Health System: The Foundation for Continuous Improvement in Health and Health Care: Workshop Series Summary.?? Grossmann C, Powers B, McGinnis JM eds. Institute of Medicine (2011)
  1. ]
  2. Kush RD.
    Interoperability for the Learning Health System.
    Digital Infrastructure for the Learning Health System: The Foundation for Continuous Improvement in Health and Health Care: Workshop Series Summary. Grossmann C, Powers B, McGinnis JM eds. Institute of Medicine (2011) pp.108-114.
\
  1. [
[
  1. Online
|http://books.nap.edu/openbook.php?record_id=12912&page=108]\] h2. Coalition for Accelerating Standards and Therapies (CFAST) CFAST is a joint initiative of the Clinical Data Interchange Standards Consortium (CDISC) and the Critical Path Institute
  1. ]

Coalition for Accelerating Standards and Therapies (CFAST)

CDISC (see http://www.cdisc.org/cfast-0) and C-Path (see http://c-path.org/programs/cfast/), and on the FDA [Therapeutic Areas Web page|http://www.fda.gov/drugs/developmentapprovalprocess/formssubmissionrequirements/electronicsubmissions/ucm287408.htm]. Therapeutic area teams follow a CFAST-approved process that incorporates stakeholder inputs and public review to produce therapeutic area user guides, questionnaire supplements and controlled terminology. Controlled terminology goes through an extensive process of content development and public review before it is declared ready for release. All controlled terminology developed by the therapeutic area teams is published as part of the CDISC controlled terminology standards. For more information on CDISC controlled terminology, visit the NCI website [http://www.cancer.gov/cancertopics/cancerlibrary/terminologyresources/CDISC]. EVS Related References # Haber MW, Kisler BW, Lenzen M, Wright LW. *Controlled Terminology for Clinical Research: A Collaboration between CDISC and NCI Enterprise Vocabulary Services.* ??Drug Information Journal??

Therapeutic area teams follow a CFAST-approved process that incorporates stakeholder inputs and public review to produce therapeutic area user guides, questionnaire supplements and controlled terminology. Controlled terminology goes through an extensive process of content development and public review before it is declared ready for release. All controlled terminology developed by the therapeutic area teams is published as part of the CDISC controlled terminology standards.

For more information on CDISC controlled terminology, visit the NCI website CDISC Terminology resources.

EVS Related References

  1. Haber MW, Kisler BW, Lenzen M, Wright LW.
    Controlled Terminology for Clinical Research: A Collaboration between CDISC and NCI Enterprise Vocabulary Services.
    Drug Information Journal 2007;41(3):405-412.
\
  1. [
[
  1. PDF
|http://www.cdisc.org/system/files/all/reference_material/application/pdf/diaj_terminology.pdf]\] #
  1. ]
  2. U.S.
  1. Food
  1. and
  1. Drug
  1. Administration.
*

  1. FDA
  1. Therapeutic
  1. Area
  1. Standards
  1. (TAS)
  1. Initiative
  1. Project
  1. Plan,
  1. Version
  1. 2.0.
*

  1. June
  1. 2014.
\
  1. [
[PDF|http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/FormsSubmissionRequirements/ElectronicSubmissions/UCM371691.pdf]\] h2. National Council of Prescription Drug Providers (NCPDP) NCPDP is a
  1. PDF]

National Council of Prescription Drug Providers (NCPDP)

NCPDP is a not-for-profit,

ANSI-accredited,

Standards

Development

Organization

with

over

1,600

members

representing

virtually

every

sector

of

the

pharmacy

services

industry.

NCPDP

creates

and

promotes

the

transfer

of

data

related

to

medications,

supplies,

and

services

within

the

healthcare

system

through

the

development

of

standards

and

industry

guidance.

In

2009,

NCPDP

decided

to

partner

with

EVS

to

use

NCIt

subsets

to

support

two

of

those

standards,

employed

by

some

200

vendors

serving

approximately

15,000

pharmacies

nationwide:

* *

  • NCPDP
  • SCRIPT
  • Standard
*
  • supports
  • messages
  • for
  • new
  • prescriptions,
  • prescription
  • changes,
  • refill
  • requests,
  • prescription
  • fill
  • status
  • notification,
  • prescription
  • cancellation,
  • medication
  • history,
  • and
  • transactions
  • for
  • long
  • term
  • care
  • environments.
  • Many
  • large
  • providers
  • such
  • as
  • First
  • DataBank
  • and
  • Surescripts,
  • the
  • nation's
  • largest
  • e-prescriber,
  • use
  • this
  • standard.
  • Surescripts
  • alone
  • connects
  • thousands
  • of
  • pharmacies
  • across
  • the
  • US,
  • and
  • is
  • connected
  • to
  • the
  • largest
  • network
  • of
  • payers
  • and
  • Medicaid
  • Fee
  • for
  • Service
  • payers
  • nationwide.
* *
  • NCPDP
  • Telecommunication
  • Standard
*
  • supports
  • the
  • electronic
  • communication
  • of
  • claims
  • and
  • other
  • transactions
  • between
  • pharmacy
  • providers,
  • insurance
  • carriers,
  • third
  • party
  • administrators,
  • and
  • other
  • responsible
  • parties.
  • It
  • is
  • the
  • standard
  • used
  • for
  • eligibility,
  • claims
  • processing,
  • reporting
  • and
  • other
  • pharmacy
  • industry
  • communications,
  • as
  • designated
  • in
  • HIPAA.
  • More
  • than
  • 4
  • billion
  • claims
  • are
  • processed
  • each
  • year
  • using
  • this
  • standard.

For

more

information,

visit

the

NCI

website [http://www.cancer.gov/cancertopics/cancerlibrary/terminologyresources/ncpdp|http://www.cancer.gov/cancertopics/cancerlibrary/terminologyresources/ncpdp]. +EVS Related References+ # Liu H, Burkhart Q, Bell DS. *Evaluation of the NCPDP Structured and Codified Sig Format for e-prescriptions.* ??J Am Med Inform Assoc??. 2011 Sep

website NCPDP Terminology resources.

EVS Related References

  1. Liu H, Burkhart Q, Bell DS.
    Evaluation of the NCPDP Structured and Codified Sig Format for e-prescriptions.
    J Am Med Inform Assoc. 2011 Sep 1;18(5):645-51.
  1. Epub
  1. 2011
  1. May
  1. 25.
  1. PubMed
  1. PMID:
  1. 21613642;
  1. PubMed
  1. Central
  1. PMCID:
  1. PMC3168301.
\
  1. [
[
  1. PubMed
|http://www.ncbi.nlm.nih.gov/pubmed/21613642]\] h2. Federal Medication Terminologies
  1. ]

Federal Medication Terminologies (FMT)

Work

started

in

2002

as

an

interagency

collaboration

between

NCI

EVS,

FDA,

VHA,

and

NLM

--

joined

later

by

AHRQ,

CMS,

DoD,

and

EPA

--

to

improve

the

exchange

and

public

availability

of

medication

information

with

coordinated

development

of

terminology

standards.

The

initial

FMT

terminology

set

has

been

endorsed

by

U.S.

Federal

standards

efforts

including

the

National

Committee

on

Vital

and

Health

Statistics

(NCVHS),

Consolidated

Health

Informatics

(CHI),

the

Healthcare

Information

Technology

Standards

Panel

(HITSP),

and

the

Office

of

the

National

Coordinator

for

Health Information Technology (ONC) within the Department of Health and Human Services (HHS). For more information, visit the NCI website [http://www.cancer.gov/cancertopics/cancerlibrary/terminologyresources/fmt|http://www.cancer.gov/cancertopics/cancerlibrary/terminologyresources/fmt]. h2. Veterans Health Administration (VHA) VHA has worked closely with EVS since 2002. Under an ongoing Memorandum of Understanding, VHA works with EVS on collaborative terminology policy and products, including content collaboration and publication of the VA's National Drug File Reference Terminology

Health Information Technology (ONC) within the Department of Health and Human Services (HHS).

For more information, visit the NCI Website Federal Medication Terminologies resources.

Veterans Health Administration (VHA)

VHA has worked closely with EVS since 2002. Under an ongoing Memorandum of Understanding, VHA works with EVS on collaborative terminology policy and products, including content collaboration and publication of the VA's National Drug File Reference Terminology (NDF-RT),

used

by

both

agencies

as

a

drug

information

reference

resource.

The

VHA

also

performed

a

thorough

comparison

of

the

functional

capabilities

of

LexEVS

to

those

of

other

terminology

servers.

The

VA

provided

the

results

to

the

VKC,

which

transformed

the

matrix

into

a

document

that

can

be

used

by

potential

adopters

of

LexEVS

as

they

evaluate

the

capabilities

of

the

system.

This

is

an

example

of

a

valuable

contribution

from

the

community

that

is

not

code-based;

in

an

open

source

model,

contributions

of

documentation

can

be

as

important

as

contributions

of

code.

h2.

Medical

Dictionary

for

Regulatory

Activities

(MedDRA)

MedDRA

is

an

international

terminology

for

coding

and

regulatory

reporting

of

drug

and

device

adverse

events.

MedDRA

is

an

International

Conference

on

Harmonisation

of

Technical

Requirements

for

Registration

of

Pharmaceuticals

for

Human

Use

(ICH)

standard,

adopted

by

FDA

and

many

other

agencies.

MedDRA

is

used

by

more

than

3,000

regulatory,

industry

and

academic

subscribers

from

60

countries,

and

has

been

translated

into

11

languages.

EVS

manages

the

MedDRA

license

for

NIH,

and

publishes

multiple

versions

through

LexEVS,

the

NCI

Term

Browser,

and

other

means.

EVS

maintains

multiple

versions

of

MedDRA

on

its

servers

and

browsers

to

support

validation

and

interpretation

of

data

encoded

with

those

versions.

Over

10

years,

EVS

has

performed

numerous

mapping

comparisons

between

MedDRA

and

NCI

terminologies

including

NCI

Thesaurus,

PDQ,

CTEP

SDC,

and

CTCAE,

as

part

of

ongoing

efforts

to

promote

compatibility

and

data

translation

between

these

sources.

NCI

Metathesaurus

maintains

mappings

between

MedDRA

and

more

than

70

other

biomedical

terminologies,

providing

a

rich

source

of

additional

description

of

MedDRA

terms

and

supporting

data

translation

and

analysis.

EVS

and

the

[

MedDRA

Maintenance

and

Support

Services

Organization

(MSSO)

|http://www.meddramsso.com/]

are

working

with

the

[

UK

Medicines

and

Healthcare

products

Regulatory

Agency

(MHRA)

|http://www.mhra.gov.uk/]

on

use

of

the

EVS

Mapping

Tool

to

develop

an

initial

proof-of-concept

mapping

from

SNOMED

CT

to

MedDRA,

focusing

on

high

frequency

adverse

event

terms

to

test

the

possibility

of

automated

conversion

of

EHR

data

to

support

more

proactive

identification

of

potential

signals

with

drugs

that

have

gained

marketing

approval.

EVS

has

also

made

numerous

contributions

to

updates

of

MedDRA

terminology.

EVS

conducted

a

comprehensive

review

of

the

over

8,500

terms

in

MedDRA's

Neoplasm

classification,

suggesting

changes

initially

presented

to

a

special

Blue

Ribbon

Panel

meeting

in

2011

with

a

follow-up

Panel

to

be

convened

in

2012.

NCI

Thesaurus

is

used

as

the

primary

reference

terminology

for

updates

to

MedDRA

neoplastic

terminology.

h2.

World

Health

Organization

(WHO)

The

International

Classification

of

Diseases

(ICD)

is

the

global

standard

diagnostic

classification

for

all

general

epidemiological

and

many

health

management

purposes,

and

has

many

clinical

uses.

WHO

work

on

the

International

Classification

of

Diseases

11th

revision

(ICD-11)

is

using

NCI

Thesaurus

(NCIt)

as

an

important

source

of

cancer-related

terminology,

relationships,

and

other

features

such

as

definitions.

EVS

has

helped

facilitate

access

to

and

reuse

of

NCIt

content,

as

well

as

expert

review

and

suggestions

on

some

draft

ICD-11

content;

the

oncology-specific

ICD-O

is

also

being

influenced

by

NCIt's

in-depth

characterization

of

cancers

and

other

neoplasms.

WHO

is

also

taking

advantage

of

EVS-supported

open

source

terminology

tooling

in

its

work.

In

June

2009,

WHO

requested

a

Classification

Markup

Language

(ClaML)

LexEVS

data

processing

program

that

could

be

used

to

render

ICD-10

in

preparation

for,

and

as

the

foundation

of,

ICD-11.

Stanford

University's

Protégé

and

related

terminology

editing

tools

are

also

a

vital

component

of

WHO

efforts.

h2.

Health

Level

7

(HL7)

EVS

supports

terminology

content

for

the

Regulated

Clinical

Research

Information

Management

(RCRIM)

committee

of

HL7,

and

for

other

committees

as

appropriate

including

Patient

Safety,

Pharmacy,

Clinical

Genomics,

and

the

Clinical

Interoperability

Council.

h2.

The

Taiwan

Cancer

Registry

The

Taiwan

Cancer

Registry,

a

population-based

cancer

registry

founded

in

1979,

uses

NCI

Thesaurus

terminology.

Hospitals

with

greater

than

50-bed

capacity

that

provide

outpatient

and

hospitalized

cancer

care

are

recruited

to

participate

in

reporting

all

newly

diagnosed

malignant

neoplasms

to

this

registry.

+

EVS

Related

References

+ #

  1. Chen
  1. S,
  1. Hsu
  1. C.
*

  1. The
  1. TCR
  1. Cancer
  1. Registry
  1. Repository
  1. for
  1. Annotating
  1. Cancer
  1. Data.
* ??

  1. Emergency
  1. Management
  1. and
  1. Management
  1. Sciences
  1. (ICEMMS),
  1. 2011
  1. 2nd
  1. IEEE
  1. International
  1. Conference
  1. on
??
  1. ,
  1. 2011
  1. Aug
  1. 8-10:297-300.
\
  1. [
[
  1. IEEE
|http://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=6015680&isnumber=6015603
  1. ]
\] {multi-excerpt}

Wiki Markup
{scrollbar:icons=false}